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Distinct associations of Motor 
Domains in relatives of 
schizophrenia Patients—Different 
Pathways to Motor abnormalities  
in schizophrenia?
Lea Schäppi*, Katharina Stegmayer, Petra V. Viher and Sebastian Walther
University Hospital of Psychiatry, University of Bern, Bern, Switzerland
introduction: Aberrant motor function is an integral part of schizophrenia. In fact, abnor-
malities are frequently found in patients, in populations at risk, and in unaffected relatives. 
Motor abnormalities are suspected to be relevant for the clinical outcome and could 
probably predict the conversion from at-risk individuals to schizophrenia. Furthermore, 
motor function has been argued as endophenotype of the disorder. Yet, which particular 
motor domain may classify as a potential endophenotype is unknown. We aimed to 
compare schizophrenia patients, unaffected first-degree relatives and healthy controls 
for different motor domains. We expected impairments in all domains in patients and in 
some domains in relatives.
Method: We included 43 schizophrenia patients, 34 unaffected first-degree relatives 
of schizophrenia patients, and 29 healthy control subjects, matched for age, gender, 
and education level. We compared motor function of four motor domains between the 
groups. The domains comprise neurological soft signs (NSS), abnormal involuntary 
movements (dyskinesia), Parkinsonism, and fine motor function including simple [finger 
tapping (FT)] and complex fine motor function, (i.e., dexterity as measured with the 
coin rotation test). Furthermore, we tested the association of motor function of the four 
domains with working memory, frontal lobe function, and nonverbal intelligence for each 
group separately using within-group bivariate correlations.
results: Schizophrenia patients showed poorer motor function in all tested domains 
compared to healthy controls. First-degree relatives had intermediate ratings with aber-
rant function in two motor domains. In detail, relatives had significantly more NSS and 
performed poorer in the FT task than controls. In contrast, complex fine motor function 
was intact in relatives. Relatives did not differ from controls in dyskinesia or Parkinsonism 
severity.
Discussion: Taken together, schizophrenia patients have motor abnormalities in all 
tested domains. Thus, motor abnormalities are a key element of the disorder. Likewise, 
first-degree relatives presented motor deficits in two domains. A clear difference between 
relatives and healthy controls was found for NSS and FT. Thus, NSS and FT may be 
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potential markers of vulnerability for schizophrenia. The lack of association between 
genetic risk and dyskinesia or Parkinsonism suggests distinct pathobiological mecha-
nisms in the various motor abnormalities in schizophrenia.
Keywords: neurological soft signs, fine motor function, relatives of schizophrenia, motor function, dimension, 
schizophrenia
inTrODUcTiOn
Motor abnormalities constitute an integral part of schizophrenia. 
Aberrant motor function was included as one of eight dimensions 
of psychopathology in schizophrenia spectrum disorders in the 
current version of the diagnostic and statistical manual (DSM-5) 
(2014). Aberrant motor function was frequently observed in both 
medicated and unmedicated patients (1, 2). In addition, aberrant 
motor function often wax and wane during follow-up (3, 4). At 
least one motor sign was present in about 66% of patients in first-
episodes (5), in 59% of patients on admission (6), and 80% of 
chronic patients (1, 7). Alterations incorporate various domains 
of motor function. Domains include for instance neurological soft 
signs (NSS) (i.e., motor coordination, sequencing, and sensory 
integration) (8), dyskinesia (abnormal involuntary movements 
typically manifest as involuntary continuous orofacial move-
ments and dyskinetic movements of the extremities or trunk) (9, 
10), parkinsonism (bradykinesia, rigor, tremor) (10), catatonic 
symptoms (pure motor signs, disturbance of volition, inability to 
suppress motor reactions and vegetative instability) [for review, 
see e.g., Ref. (1, 11, 12)], deficits in fine motor function [i.e., 
the coin rotation task, the Moberg pick-up test (13, 14), finger 
sequencing and the pegboard test (15)], and psychomotor slowing 
(16). In sum, schizophrenia patients show generalized aberrant 
motor function.
Another important line of evidence stems from first-degree 
relatives of psychosis patients. Aberrant motor function in these 
subjects may help find markers who are associated with the genetic 
risk for schizophrenia. However, a comprehensive assessment of a 
wide range of domains of motor function in first-degree relatives 
is missing. Thus, it remains unknown, which particular motor 
domain may serve as a potential genetic risk marker.
In detail, previous reports suggest delayed motor develop-
ment as a genetic risk marker. For instance, it was hypothesized 
that NSS arise due to neurodevelopmental delay in motor 
function in young subjects at risk and first-degree relatives. 
NSS are subtle neurological deficits (17, 18) which are seen in 
children and normally vanish during the motor development 
in late childhood. An association of NSS with the genetic risk 
for schizophrenia has consistently been reported (19), possibly 
even predictive for the transition to psychosis (20). Nearly, all 
studies investigating NSS in unaffected first-degree relatives 
detected higher prevalence of NSS in relatives compared to 
healthy controls. This has been substantiated by recent meta-
analyses (8, 21).
Whether dyskinesia and Parkinsonism are associated with the 
genetic risk to develop schizophrenia is less clear than for NSS 
(22, 23). Even though, most reports show increased incidence 
of dyskinesia and Parkinsonism in schizophrenia relatives, 
which has been confirmed in a recent meta-analysis (24). Yet, 
for instance, Tarbox and Pogue-Geile (25) detected no increased 
prevalence of dyskinesia in relatives. As for dyskinesia, from the 
available data, it is difficult to state whether Parkinsonism may 
serve as a genetic risk marker for psychosis. Some reports showed 
increased incidence in unaffected relatives (24, 26) with some 
inconsistency (27).
One further important domain of motor function is fine motor 
function (i.e., manual skills and dexterity) (28). Schizophrenia 
patients suffer from defective complex fine motor function, as 
measured by the Line Copying Task or the coin rotation test (14) 
as well as simple fine motor function as measured by the finger 
tapping (FT) task [e.g., Ref. (14, 29, 30)]. Fine motor impairments 
are already present at the beginning of the disorder in the first 
episode. These deficits seem to be relatively stable over time (31). 
Moreover, defective fine motor function may impact activities of 
daily living and may be associated with poor functional outcome 
as has been shown in other conditions (i.e., Parkinson’s disease) 
(32, 33) In general, a loss of complex fine motor skills may not 
solely be explained by elemental motor deficits such as motor 
slowing (bradykinesia) but might also reflect disturbances of 
more complex motor function such as selectively control and 
coordination of upper limb and specifically finger movements 
(34, 35). Whether fine motor function is linked to the genetic 
risk for psychosis is unclear. One single report detected aberrant 
simple fine motor function (measured with FT) in unaffected 
first-degree relatives of psychotic patients (36). Likewise another 
study found reduced complex fine motor function (i.e., tested 
with inserting long and short pins into holes in a platform) in 
subjects at risk (37). However, complex fine motor function of 
the fingers (i.e., finger dexterity measured with the coin rotation 
task) has not been tested.
In sum, there is considerable and consistent evidence for the 
association of NSS and the risk to develop schizophrenia. A mod-
erate number of studies suggest an association of dyskinesia and 
Parkinsonism with schizophrenia risk with some inconsistency. 
In addition, only few studies addressed the association of com-
plex fine motor function and psychosis risk. Moreover, former 
investigations focused only on one motor domain. Thus, which 
domain of motor function is associated with a genetic psychosis 
risk and how they are interlinked is still unknown.
Therefore, the aim of our study was to compare for the first 
time a comprehensive motor battery, including motor function 
in four domains (NSS, dyskinesia, Parkinsonism and fine motor 
function) in three well-characterized groups (patients, unaffected 
first-degree relatives and healthy controls). In line with the litera-
ture, we expected generalized aberrant motor function in schizo-
phrenia patients. Further, we expected aberrant motor function 
in some but not all motor domains in unaffected first-degree 
Table 1 | Demographic data and clinical status of the groups.
controls (c); N 29 relatives (r); N 34 Patients (P); N 43 df F/χ2 p-Value
Age 40.86 ± 14.38 42.74 ± 15.73 37.98 ± 11.37 2 1.18 0.312
Gender 55.2% (f) 64.7% (f) 62.8% (f) 2 0.67 0.768
EDU 13.79 ± 2.32 14.18 ± 3.02 13.52 ± 3.12 2 0.49 0.617
DOI (years) – – 12.92 ± 12.48
PANSS tot – – 71.14 ± 16
PANSS pos – – 17.98 ± 6.28
PANSS neg – – 18.14 ± 5.15
N, number; f, female; EDU, education (years); DOI, duration of illness; PANSS, Positive and Negative Syndrome Scale; tot, total; pos, positive; neg, negative.
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relatives. In detail, we hypothesized increased incidence of NSS 
and aberrant fine motor function in unaffected relatives, but no 
increased incidence of dyskinesia and Parkinsonism.
MaTerials anD MeThODs
subjects
This study included 41 patients with schizophrenia, 34 first-
degree relatives (parents, siblings, or children) and 29 healthy 
controls matched for gender, age, and education. All participants 
were right-handed as determined by the Edinburgh handedness 
inventory (38) and were native German speakers. This study was 
carried out in accordance with the recommendations of the local 
Ethics Committee (Kantonale Ethikkommission: KEK Bern) 
with written informed consent from all subjects.
Patients were in- and outpatients recruited at the University 
Hospital of Psychiatry, Bern and diagnosed according to DSM-5. 
Relatives were contacted via patients with schizophrenia and the 
Association of Schizophrenia Patients’ Relatives, Bern. Inclusion 
criterion for relatives was a history or presence of any physician-
diagnosed schizophrenia spectrum disorder in at least one 
first-degree relative. Controls were volunteers recruited from the 
hospital staff and the community without first-degree relatives 
with schizophrenia spectrum disorders.
General exclusion criteria for all participants were substance 
abuse or dependence other than nicotine and past or current 
medical or neurological condition associated with impaired 
movement (i.e., dystonia, idiopathic Parkinsonism, or stroke).
All Participants were interviewed by trained psychiatrists using 
the Mini-International Neuropsychiatric Interview (39) (adapted 
for DSM-5). In addition, we assessed frontal lobe function using 
the Frontal Assessment Battery (FAB) (40), verbal working memory 
with the digit span backwards (DSB) task [subtest from the Wechsler 
Memory Scale (WMS-III)] (41) as well as nonverbal intelligence 
using the short Test of nonverbal Intelligence (TONI) (42).
Motor behavior
We assessed four different domains of motor function using a com-
prehensive battery including the neurological evaluation scale 
(NES) (18) to assess NSS, the Abnormal Involuntary Movement 
Scale (AIMS) (43) for dyskinesia, and the Unified Parkinson’s 
Disease Rating Scale (UPDRS) (44) for Parkinsonism. In addi-
tion, participants performed a complex and a simple fine-motor 
tasks. During the complex fine-motor task, the coin rotation 
task (CR), a coin (Swiss 50-Rappen coin, corresponding exactly 
in size to a US-Nickel) is rotated between thumb and fingers one 
and two (index and middle finger) in 10 s as fast as possible. A 
correction for drops is used [the adjusted score is the number of 
rotations in 10 s minus (0.1 × rotations × drops)] (34, 45, 46). 
After a short training period, each participant performed three 
trials of 10 s with each hand. Performance was videotaped and 
analyzed in slow motion by a blinded rater. The last half-turn 
was included when at least half of the movement was completed. 
Finally, participants performed a simple fine motor task, the 
FT task. They were instructed to tap their index finger and 
thumb with the maximum amplitude as fast as possible. This 
task was also performed for three times during 10 s with each 
hand. Again, performance was video recorded and analyzed by 
a blinded rater.
statistical analysis
Statistical tests were performed using SPSS 24.0 (SPSS Inc., 
Chicago, IL, USA). Univariate analysis of variance, chi-square 
tests (χ2), and general linear models were used to test the continu-
ous and categorical clinical variables between groups (relatives, 
patients and controls). Our main interest was to assess whether 
patients and relatives had more severe motor abnormalities than 
controls. Therefore, we first compared ratings of motor scales 
between groups using univariate analyses of variance. Post hoc 
tests included Sidak correction for multiple comparisons. Next, 
we calculated two separate repeated measures ANOVAs of perfor-
mance in the two fine motor tasks with side (left and right hand) 
as within-subject factor. To test the association of aberrant motor 
function as well as working memory and frontal lobe function, we 
correlated scores of each scale and task for each group (patients, 
relatives and controls) separately, applying within-group bivariate 
correlations. Significance level was set at p < 0.05 two-tailed.
resUlTs
Clinical and demographic data are given in Table 1. Groups did 
not differ in age, gender, and education. However, groups dif-
fered regarding nonverbal intelligence and working memory, for 
which patients had inferior performance compared to relatives or 
controls. In addition, patients had poorer frontal lobe function at 
trend level (p = 0.081) compared to healthy controls (see Table 2).
Motor Function
Groups differed in incidence of aberrant motor function in the 
applied motor scales (see Table 3 and Figure 1). In detail, patients 
FigUre 1 | Group differences of neurological soft sign, dyskinesia, and Parkinsonism in patients, relatives, and controls. Error bars indicate SE. NES, Neurological 
Evaluation Scale; sub., subscale; sen., sensory motor function; mot., motor coordination; seq., motor sequencing; AIMS, Abnormal Involuntary Movement Scale; 
UPDRS III, Unified Parkinson’s Disease Rating Sale motor part III.
Table 2 | Nonverbal intelligence, frontal lobe and working memory function of the groups.
controls (c); N 29 relatives (r); N 34 Patients (P); N 43 df F/χ2 p-Value Post hoc
sidak corrected
TONI 109.24 ± 10.50 108.15 ± 8.43 97.68 ± 11.40 2 14.28 <0.001 P < c (p < 0.001)
P < r (p < 0.001)
FAB 17.17 ± 0.97 16.85 ± 1.54 16.10 ± 2.72 2 2.78 0.067 P < C (p < 0.081)
DSB 5.31 ± 0.71 5.26 ± 0.79 4.42 ± 1.05 2 9.45 <0.001 P < c (p = 0.001)
P < r (p = 0.001)
N, number; TONI, test of nonverbal intelligence (index scores); FAB, frontal assessment battery; DSB, digit span backwards.
Note: significant group differences are highlighted in bold.
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and relatives had higher NSS ratings than healthy controls, indicat-
ing more pathological signs. Next, we explored group differences 
in NSS subdomains (NES subscales). Again, groups differed in all 
measured motor functions (sensory motor function, motor coor-
dination, motor sequencing, and others). In detail, performance of 
patients was worse in all subscales compared to healthy controls. 
Relatives demonstrated inferior performance in “motor sequenc-
ing” and “others,” as well as a trend of inferiority in “sensory integra-
tion” (p = 0.067) compared to healthy controls. For dyskinesia and 
Parkinsonism differences became evident between patients and 
healthy controls, but not between relatives and controls.
In addition, we tested complex (CR) and simple fine motor 
function (FT) (Table 4; Figure 2) exploring effects of side (left 
or right hand), group and group*side interactions. For CR, we 
found an effect of side in favor of the right hand, an effect of group 
but no group*side interaction. Post hoc Sidak tests indicated CR 
was impaired in patients compared to controls. Relatives did not 
differ from controls. Likewise, in FT, we detected an effect of side 
in favor of the right hand, an effect of group but no group*side 
interaction. Post hoc Sidak tests indicated that patients and rela-
tives performed inferior to controls.
association of Motor Function With 
Frontal lobe Function and Working 
Memory
The association of motor domains including fine motor func-
tion with frontal lobe function and working memory is given 
in Table 5. Table 4 shows that ratings of some motor domains 
correlated with performance in motor tests. In fact, fine motor 
tests (CR and FT) are significantly associated with Parkinsonism 
in patients and unaffected relatives. Likewise, CR is significantly 
associated with NSS in patients. In contrast, dyskinesia (AIMS) 
seems to be independent of fine motor function (CR and FT). In 
addition, CR is unrelated to frontal lobe function in all groups 
and to working memory in relatives and controls. Furthermore, 
Table 3 | Group differences of neurological soft sign, dyskinesia, and Parkinsonism in patients, relatives, and controls.
controls (c); N 29 relatives (r); N 34 Patients (P); N 43 F p-Value Post hoc
sidak corrected
NES total 3.90 ± 3.59 11.65 ± 8.18 13.74 ± 11.75 10.83 <0.001 r > c (p = 0.003)
P > c (p < 0.001)
NES
Sensory integration
1.14 ± 1.19 2.94 ± 2.15 3.58 ± 5.12 4.23 0.017 P > c (p = 0.015)
NES
Motor coordination
0.55 ± 0.78 1.79 ± 1.82 2.60 ± 2.84 8.09 0.001 P > c (p < 0.001)
NES
Sequencing
1.03 ± 1.96 3.21 ± 2.72 2.60 ± 2.96 6.39 0.002 r > c (p = 0.005)
P > c (p = 0.008)
NES
Others
1.14 ± 1.43 3.71 ± 3.44 4.88 ± 4.73 9.12 <0.001 r > c (p = 0.020)
P > c (p < 0.001)
AIMS total 0.14 ± 0.52 1.15 ± 2.36 1.91 ± 2.7 5.62 0.005 P > c (p = 0.003)
AIMS
Facial expression
0.04 ± 0.19 0.27 ± 0.75 0.26 ± 0.74 1.3 0.277
AIMS
Lips and perioral area
0.10 ± 0.41 0.32 ± 0.73 0.23 ± 0.43 1.27 0.285
AIMS
Jaw
0.0 ± 0.0 0.09 ± 0.38 0.11 ± 0.40 1.03 0.363
AIMS
Tongue
0.0 ± 0.0 0.15 ± 0.58 0. 17 ± 0.51 1.31 0.276
AIMS
Upper extremity
0.0 ± 0.0 0.15 ± 0.50 0.37 ± 0.77 3.77 0.027 P > c (p = 0.024)
AIMS
Lower extremity
0.0 ± 0.0 0.0 ± 0.0 0.31 ± 0.68 6.79 0.002 P > c (p = 0.008)
P > r (p = 0.005)
AIMS
Neck/shoulders/hips
0.0 ± 0.0 0.12 ± 0.48 0.143 ± 0.43 1.23 0.296
UPDRS III 0.10 ± 0.56 2.50 ± 3.93 7.21 ± 7.46 17.19 <0.001 P > r (p = 0.001)
P > c (p < 0.001)
AIMS, Abnormal Involuntary Movement Scale; NES, Neurological Evaluation Scale; UPDRS III, Unified Parkinson’s Disease Rating Sale motor part III.
Note: significant group differences are highlighted in bold.
FigUre 2 | Performance of fine motor function in patients, relatives, and controls. Coin rotation: effect of group p = 0.001, effect of side p < 0.001, no effect 
side × group: p = 0.822; post hoc: patients < controls: p = 0.003; and relatives < controls p = 0.005. Finger tapping: effect of group: p = 0.018, effect of side: 
p < 0.001, no effect side × group: p = 0.646; post hoc: patients < controls: p = 0.061 and relatives < controls p = 0.022.
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frontal lobe function is associated with NSS and Parkinsonism 
in all groups. Likewise, WM was significantly correlated with 
motor function in patients. This association is not seen in any 
other group.
DiscUssiOn
Increasing evidence has established the clinical relevance of 
aberrant motor function in schizophrenia (1, 47–49). Here, we 
Table 4 | Performance of fine motor function in patients, relatives and controls.
controls (c); N 29 relatives (r); N 34 Patients (P); N 43
CR right (±SE) 14.61 ± 2.97 14.47 ± 2.87 11.96 ± 3.67
CR left (±SE) 12.82 ± 3.09 12.49 ± 2.87 10.31 ± 4.05
FT right (±SE) 39.95 ± 8.40 33.77 ± 7.55 35.07 ± 9.49
FT left (±SE) 37.44 ± 9.15 32.10 ± 6.75 32.82 ± 9.29
CR, coin rotation; FT, finger tapping.
Table 5 | Association of motor function with frontal lobe function and working 
memory function in patients, relatives and controls.
aiMs UPDrs 
iii
cr FT Fab WM
Patients
NES 0.357* 0.760** -0.541** −0.300 −0.628** −0.479**
AIMS 0.303* −0.266 −0.046 −0.122 −0.101
UPDRS III −0.479** −0.412** −0.522** −0.264
CR 0.195 0.349*
FT 0.077 0.116
FAB 0.492**
WM
relatives
NES 0.283 0.356* −0.403* −0.438** −0.399* −0.299
AIMS −0.060 −0.318 0.073 0.031 −0.378*
UPDRS III −0.341* −0.496** −0.419* −0.230
CR 0.144 0.072
FT 0.464** 0.017
FAB 0.307
WM
controls
NES 0.471** 0.488** −0.337 −0.271 −0.613** −0.197
AIMS 0.694** −0.041 −0.169 −0.623** −0.121
UPDRS III −0.104 −0.007 −0.432* −0.084
CR 0.335 −0.155
FT 0.312 −0.027
FAB 0.127
WM
NES, Neurological Evaluation Scale; AIMS, Abnormal Involuntary Movement Scale; 
UPDRS III, Unified Parkinson’s Disease Rating Scale motor part III; CR, coin rotation; 
FT, finger tapping; FAB, frontal assessment battery; DSB, digit span backwards.
*p < 0.05; **p < 0.01.
Note: significant associations are highlighted in bold.
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investigated a comprehensive motor battery with four domains 
of motor function in three well-characterized groups (patients, 
unaffected first-degree relatives and healthy controls). The study 
aimed to explore, which motor domains were particularly associ-
ated with the genetic risk for psychosis. We were able to confirm 
our main hypotheses, and demonstrated (1) generalized aberrant 
motor function in schizophrenia patients, and (2) aberrant motor 
function in some but not all motor domains in schizophrenia 
relatives. The distinct pattern of associations between genetic 
psychosis risk and motor domains argues for different patho-
physiological mechanisms behind each motor domain.
As hypothesized, aberrant motor function was shown for NSS 
in schizophrenia relatives compared to controls with intermedi-
ate severity. Moreover, NSS are thought to indicate aberrant 
motor development that is even evident in adults. Aberrant motor 
development has been associated with a genetic psychosis risk 
(9). Thus, NSS have been discussed as endophenotype markers 
in psychosis (50). In contrast, we were not able to confirm our 
hypothesis of an association between genetic psychosis risk and 
defective coin rotation, which is a reliable and simple measure 
of complex fine motor function. In fact, in unaffected first-
degree relatives fine motor function was preserved. However, in 
schizophrenia we detected aberrant complex fine motor function 
with the coin rotation task. In addition, patients and relatives 
performed worse than healthy controls in the simple fine motor 
task. Finally, relatives had similar severity of Parkinsonism and 
dyskinesia compared to healthy controls, which is different from 
the findings regarding NSS. Thus, our results confirm the specific 
importance of NSS for the genetic psychosis risk. Therefore, NSS 
may in the future be particularly useful to monitor vulnerable 
subjects.
generalized aberrant Motor Function in 
schizophrenia
Patients had an increased severity of NSS, dyskinesia and 
Parkinsonism. In addition, we detected aberrant fine motor 
function (FT and CR) in patients. Thus, in line with the literature 
we found generalized aberrant motor function in schizophrenia 
patients and extended the knowledge by demonstrating further 
alterations in complex fine motor function, which has been 
understudied. Complex fine motor function (i.e., manual dexter-
ity as measured with the CR task) adopts an intermediate position 
between higher-order (i.e., apraxic) and elemental motor func-
tion. Aberrant complex fine motor function is characterized by 
impaired control of selective and coordinated hand and finger 
movements, not explained by weakness or sensory deficits (51). 
Aberrant function in this domain may impact performance of 
skilled movements in schizophrenia, such as hand gestures (14, 
52–55). Similar deficits have previously been shown in Parkinson’s 
disease (35). Taken together, exploring the pathophysiology 
underlying complex fine motor function, incorporating instru-
mental approaches, may add to the innovative research in the 
field of motor function in schizophrenia.
aberrant Motor Function in specific Motor 
Domains in Unaffected First-Degree 
relatives
Unaffected first-degree relatives of schizophrenia patients showed 
aberrant motor function in some but not all investigated motor 
domains. In line with the literature, we found more NSS in rela-
tives compared to healthy controls. Nearly all studies (56–60) 
and recent meta-analyses (8, 21) confirmed an increased sever-
ity of NSS in relatives of schizophrenia patients. Thus, NSS are 
very likely to be associated with the genetic risk for psychosis. 
However, some reports were negative, probably owing to inclu-
sion of a considerable proportion of second-degree relatives 
(61) or the lack of specific NSS rating scales (62). Besides the 
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total NSS severity, we detected differences between relatives and 
controls in two of the NES subscales, i.e., “sequencing of motor 
acts” (i.e., fist-ring test, the fist-edge-palm test, the Ozeretski 
test) and “others” (i.e., adventitious overflow, Romberg test, 
tremor, memory, mirror movements). Interestingly, a previous 
study reported increased heritability in the same subscales, with 
a correlation between NSS severity of patients and NSS severity 
of their siblings (56).
In contrast, relatives had no increased severity of dyskinesia 
and Parkinsonism in our sample. In line with this, some previ-
ous reports failed to detect increased dyskinesia in relatives (24, 
25). Likewise, one study reported a relatively low incidence of 
parkinsonism (incidence 3% of the sample in 181 subjects) 
in unaffected relatives of schizophrenia patients (27). Yet, no 
control group was included in this latter study. In contrast, other 
reports (63) demonstrate an increased severity of dyskinesia (63) 
and Parkinsonism (26, 63) in schizophrenia relatives compared 
to healthy controls. Thus, whether dyskinesia or Parkinsonism 
is truly associated with the genetic risk for psychosis requires 
further clarification in larger samples. Alternatively, dyskinesia 
and Parkinsonism may exclusively occur in subjects at increased 
risk for psychosis, who have prodromal signs beyond a genetic 
risk (23, 64, 65).
Finally, while patients showed impaired complex fine motor 
function, in relatives, complex fine motor function (CR) was 
intact. No previous report investigated complex fine motor 
function (CR) in unaffected first-degree relatives. Currently, 
our findings argue for an association of impaired complex fine 
motor function with psychosis but not with genetic psychosis 
risk. In contrast to complex fine motor function and in line with 
one previous report, simple fine motor function was impaired in 
both patients and relatives and may, therefore, be associated with 
psychosis and the genetic risk (36).
To conclude, we demonstrated increased incidence of NSS and 
impaired simple fine motor function in schizophrenia relatives 
arguing for a particular relevance as a genetic risk marker. In con-
trast, dyskinesia, Parkinsonism and complex fine motor function 
were not impaired and are, therefore, unlikely to become relevant 
indicators of the genetic risk for psychosis.
aberrant Motor Function of Different 
Domains linked to Distinct alterations  
in the Motor system
In general, motor abnormalities in schizophrenia have been con-
sistently associated with alterations in the cerebral motor system 
(48, 66–68). In addition, psychosis was associated with altered 
functional and structural connectivity in the motor system (68–77). 
Likewise, during motor tasks functional alterations in the motor 
system were detected in schizophrenia (78). Importantly, while 
there is some overlap, aberrant motor behavior of distinct motor 
domains is associated with specific structural and functional 
alterations (72, 79), i.e., not one mechanism associated with all 
domains of aberrant motor behavior in psychosis.
A large body of evidence associates NSS in schizophrenia 
with structural and functional alterations within cortical 
premotor and motor areas, the cerebellum and thalamus (48). 
In detail, NSS are linked to gray matter (GM) abnormalities in 
cortical areas comprising the pre- and postcentral gyri, premo-
tor areas, inferior and middle frontal gyri (80, 81). Likewise, 
studies using cortical thickness or sulcation found NSS to be 
associated with aberrant morphology of frontal, temporal, and 
parietal areas (82, 83). Subcortical structures related to NSS in 
schizophrenia included the thalamus, caudate nucleus, putamen, 
globus pallidus (84, 85) as well as the cerebellum (80, 86, 87). 
Importantly, even medication-naive first-episode patients show 
an association of aberrant motor sequencing and GM altera-
tions of cortical and subcortical structures (88). Interestingly, a 
longitudinal study further confirmed that persisting compared 
to decreasing NSS in first-episode schizophrenia is related to a 
progressive decrease of GM volume (89). White matter density 
has shown to be related to NSS in the inferior frontal gyrus, 
cerebellum, and corpus callosum in schizophrenia (80, 81). 
Furthermore, abnormal white matter cerebellar–thalamic tract 
development predicted NSS after 12 months in ultra-high risk 
individuals (90). Besides these structural abnormalities, some 
studies explored functional neural underpinnings of NSS (91). 
In a paradigm that compared the fist-edge-palm task with a 
simple motor task, patients with schizophrenia failed to activate 
the left middle frontal gyrus which was the case in healthy con-
trols (92). In addition, with increasing task difficulty, functional 
connectivity changed between the sensorimotor cortex and the 
right frontal gyrus in patients compared to healthy controls 
(92). Thus, altered brain morphology and function may account 
for NSS in patients.
Brain imaging studies in schizophrenia and Parkinson’s 
disease reported associations of dyskinesia and Parkinsonism 
with basal ganglia dysfunction. For instance, patients with 
dyskinesia had reduced GM volume in the caudate nucleus, 
putamen, globus pallidus, and the thalamus (93). Likewise, 
altered volume of the striatum was shown in medication 
naïve chronic schizophrenia patients with dyskinesia (94) and 
volume alterations in the putamen were evident in subjects at 
risk with dyskinesia (95). Furthermore, white matter altera-
tions within cortico-basal ganglia circuits correlated with 
involuntary movements in schizophrenia (96). Accordingly, 
early functional imaging studies reported that activity in the 
basal ganglia (higher relative metabolic rates in the putamen) 
was associated with dyskinesia severity in schizophrenia (97). 
In addition, D2/D3 receptor availability in the striatum was 
linked to Parkinsonism in schizophrenia (98). In addition, 
there is some conceptual overlap between Parkinsonism and 
reduced spontaneous motor activity, which is also paralleled 
by alterations of the cerebral motor system (72, 76, 77). 
The relatives in the current study had no increased severity 
of Parkinsonism. We may speculate that alterations in the 
suspected underlying brain areas are lacking in relatives. In 
contrast, basal ganglia shape abnormalities were also reported 
in unaffected siblings of schizophrenia patients (99). However, 
a recent study detected no alterations of caudate and puta-
men laterality indices in schizophrenia siblings, who did not 
significantly differ from controls (100) and abnormal striatal 
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and ventricle volumes showed no sign of heritability (101). 
Thus, whether alterations in the basal ganglia are critical for 
dyskinesia and Parkinsonism in relatives of schizophrenia 
patients remains to be explored.
Finally, patients had significantly impaired complex fine 
motor function. Until now, no study investigated neural cor-
relates of impaired coin rotation (complex fine motor function) 
in schizophrenia. In general, for complex fine motor function, 
temporal, and spatial information of the movement has to be 
retrieved and translated into motor output. According to mod-
ern models (102) brain areas of the so-called praxis network 
(103) are involved. Inferior parietal lobule (IPL) and intact 
connections between IPL and left premotor cortex and sup-
plementary motor area are expected to critically contribute to 
complex fine motor function (51, 104–107). In line with these 
proposed models we recently detected differentially altered 
activation and altered functional coupling in key areas of the 
left praxis network to be linked to altered complex fine motor 
function (CR) in Parkinson’s disease (35). Likewise we detected 
associations of functional and structural alterations in the praxis 
network with gesture performance in schizophrenia patients 
(108–110). However, future studies are needed to address the 
neural correlates of impaired complex fine motor function in 
schizophrenia.
association of Motor Function With 
Frontal lobe Function and Working 
Memory
Critical contributors to aberrant motor skills in schizophrenia 
are working memory and frontal lobe functioning. We, therefore, 
tested, whether frontal lobe function and working memory cor-
related with the motor domains in each group. In fact, in our 
study some motor domains (NSS and Parkinsonism) were associ-
ated with frontal lobe function across groups. However, there is 
also considerable conceptual overlap between motor skills and 
frontal lobe function. For instance the FAB and the NES share 
some items such as the fist-edge-palm test.
The pattern of correlations was different for working memory. 
Only in patients working memory was correlated with motor 
domains. This may be due to the fact that in our study working 
memory performance was relatively intact in relatives and healthy 
controls. Thus, given that motor abilities rely on frontal lobe 
and working memory function, working memory deficits may 
have impaired motor function in patients, while altered frontal 
lobe function compromised motor skills in all three groups. In 
contrast, working memory deficits were unlikely to account for 
motor abnormalities in relatives.
limitations
Some limitations of this study require discussion. The sample 
was predominantly female as women more frequently agreed 
to participation. As groups were matched for age, gender 
and education, the proportion of women was equal across 
groups. Still, former studies showed no gender effect on NSS 
severity in patients (111). In addition, most of our patients 
were medicated. Antipsychotic medication may impact motor 
behavior. For instance dyskinesia and Parkinsonism were 
typically attributed to medication (i.e., tardive dyskinesia), 
even though evidence suggests that these motor abnormalities 
may also occur spontaneously in drug naïve patients (1, 5, 10, 
112–114). We used the NES to assess NSS, but whether our 
results are comparable to other instruments remains unclear 
due to inconsistent terminology across instruments (59, 115) 
[e.g., overlap of motor coordination (116) and sequencing of 
motor acts in the NES]. Finally, although we assessed a com-
prehensive battery of various motor domains, other important 
domains have not been studied. For example, we did not test 
postural sway (117), which is an interesting measure of cer-
ebellar function.
conclusion
Modern theories for the development of psychosis suggest that 
environmental stressors, such as early childhood adversities, 
together with neurodevelopmental abnormalities may lead to 
psychosis. One particular marker of neurodevelopmental abnor-
malities is aberrant motor function. We were able to confirm 
generalized aberrant motor function in schizophrenia patients 
and aberrant motor function in some but not all tested motor 
domains in first-degree relatives of schizophrenia patients. The 
pattern of alterations in relatives suggests distinct mechanisms 
in each of the motor domains typically affected in psychosis. 
Particularly, relatives had increased NSS severity, which may 
reflect abnormal motor skill development. Thus, NSS could 
become a specific marker of the genetic risk for psychosis. 
Importantly such objective markers may not only inform on the 
etiology of psychosis but may be relevant for screening and stag-
ing of psychosis. Finally, markers of aberrant motor function may 
guide individualized treatment regimen in the future. Yet, future 
studies with sensitive technical instruments to measure and 
quantify different motor abnormalities are warranted to confirm 
our results in longitudinal studies.
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